A genome-wide association study of stroke risk in Asian statin users: evidence from KoGES and UK Biobank
This study identified <i>CDH13</i> as a significant genetic marker associated with stroke risk among Asian statin users. These findings provide the first genome-wide evidence for genetic determinants of stroke susceptibility during statin therapy, supporting the development of personalized prevention strategies in Asian populations.
Authors
- Hye Sun Gwak (ORCID: https://orcid.org/0000-0003-0278-2563)
- Da Hoon Lee (ORCID: https://orcid.org/0009-0005-6945-0127)
- SeungJin Bae (ORCID: https://orcid.org/0000-0002-8993-8884)
- Jeong Yee (ORCID: https://orcid.org/0000-0001-8439-143X)
- Yoon‐A Park (ORCID: https://orcid.org/0000-0002-9162-2555)
- Jung Sun Kim (ORCID: https://orcid.org/0000-0002-7513-4500)
- Yubin Song (ORCID: https://orcid.org/0000-0001-6933-2642)
Institutions
- Kangwon National University (KR)
- Ewha Womans University Medical Center (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Pharmacogenomics
- Published
- 2025-08-13
- DOI
- https://doi.org/10.1080/14622416.2025.2558499
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00